{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T06:36:33Z","timestamp":1792046193136,"version":"4.4.0"},"reference-count":76,"publisher":"Informa UK Limited","issue":"6","funder":[{"name":"not funded"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2022,4,13]]},"DOI":"10.1080\/14656566.2022.2042514","type":"journal-article","created":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T14:15:28Z","timestamp":1646144128000},"page":"727-737","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":9,"title":["Pharmacotherapeutic combinations for the treatment of Alzheimer\u2019s disease"],"prefix":"10.1080","volume":"23","author":[{"given":"Tomoyuki","family":"Nagata","sequence":"first","affiliation":[{"name":"Department of Psychiatry, The Jikei University School of Medicine, Tokyo, Japan"},{"name":"Department of Psychiatry, Airanomori Hospital, Kagoshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunichiro","family":"Shinagawa","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, The Jikei University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichiro","family":"Nakajima","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Noda","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Mimura","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,3,1]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30367-6"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2011.03.005"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01124-1"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(76)91936-X"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200666110-00015"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-008-1092-0"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1586\/ern.12.124"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1016\/0165-6147(91)90609-V"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201606210"},{"issue":"1","key":"cit0010","doi-asserted-by":"crossref","first-page":"e12050","DOI":"10.1002\/trc2.12050","volume":"6","author":"Cummings J","year":"2020","journal-title":"Alzheimers Dement (N Y)"},{"key":"cit0011","unstructured":"FDA\u2019s decision to approve new treatment for Alzheimer\u2019s disease. https:\/\/www.fda.gov\/drugs\/news-events-human-drugs\/fdas-decision-approve-new-treatment-alzheimers-disease. Accessed to 2021 Jul 6."},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-180766"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2019.113112"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20174272"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2006.08.036"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.56.7.857"},{"issue":"5","key":"cit0017","first-page":"115","volume":"18","author":"Matsunaga S","year":"2014","journal-title":"Int J Neuropsychopharmacol"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1106668"},{"issue":"2","key":"cit0019","first-page":"57","volume":"5","author":"Koola MM","year":"2018","journal-title":"J Geriatr Care Res"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1002\/gps.934"},{"key":"cit0021","unstructured":"ALZFORUM website https:\/\/www.alzforum.org\/therapeutics\/search?fda_statuses=&target_types=&therapy_types%5B%5D=36536&conditions%5B%5D=145&keywords-entry=&keywords=#results. Accessed to 2021 Jun 7."},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1080\/03602532.2019.1620763"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2021.1882995"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.10214"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-19641-2"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2006.03782.x"},{"key":"cit0027","first-page":"610","volume":"25","author":"Daruich A","year":"2019","journal-title":"Mol Vis"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1038\/nature20587"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2019.04.011"},{"key":"cit0030","first-page":"6852303","volume":"2018","author":"Ismail R","year":"2018","journal-title":"Int J Alzheimers Dis"},{"key":"cit0031","unstructured":"ALZFORUM website https:\/\/www.alzforum.org\/therapeutics\/search?fda_statuses%5B%5D=931&fda_statuses%5B%5D=183&target_types%5B%5D=170&target_types%5B%5D=177&therapy_types=&conditions=&keywords-entry=&keywords=. Accessed to 2021 Jun 7."},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2019.09.075"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1038\/nsmb.1437"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-021-00795-7"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.5215-08.2009"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31275-2"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-170560"},{"key":"cit0038","unstructured":"ALZFORUM website https:\/\/www.alzforum.org\/therapeutics\/search?fda_statuses%5B%5D=931&fda_statuses%5B%5D=183&target_types%5B%5D=33416&target_types%5B%5D=171&target_types%5B%5D=172&target_types%5B%5D=173&target_types%5B%5D=174&target_types%5B%5D=175&target_types%5B%5D=176&target_types%5B%5D=191&therapy_types=&conditions%5B%5D=145&keywords-entry=&keywords=. Accessed to 2021 Jun 7."},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0806142"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.1111\/j.1750-3639.1996.tb00878.x"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1111\/j.1750-3639.1996.tb00874.x"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1016\/S0896-6273(00)80191-9"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2012.11101529"},{"key":"cit0044","doi-asserted-by":"publisher","DOI":"10.1177\/0269216313493685"},{"key":"cit0045","unstructured":"clinicaltrials.gov\u2019website. 221AD301 Phase 3 Study of Aducanumab (BIIB037) in early Alzheimer\u2019s disease - full text view \u2013 clinicaltrials.gov. https:\/\/clinicaltrials.gov\/ct2\/home. Accessed to 2021 Jun 7."},{"issue":"9","key":"cit0046","first-page":"CD009132","volume":"2012","author":"Russ TC","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-015-0035-6"},{"key":"cit0048","doi-asserted-by":"publisher","DOI":"10.1002\/hipo.22405"},{"key":"cit0049","doi-asserted-by":"publisher","DOI":"10.5966\/sctm.2016-0081"},{"key":"cit0050","unstructured":"clinicaltrials.gov\u2019website. Alzheimer\u2019s autism and cognitive impairment stem cell treatment study (ACIST). https:\/\/clinicaltrials.gov\/ct2\/home. Accessed to 2021 Jun 7."},{"key":"cit0051","doi-asserted-by":"publisher","DOI":"10.1016\/j.trci.2019.01.002"},{"key":"cit0052","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2014.14040480"},{"key":"cit0053","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2009.39"},{"key":"cit0054","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.12730"},{"key":"cit0055","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2020.1745186"},{"key":"cit0056","doi-asserted-by":"publisher","DOI":"10.1002\/gps.3904"},{"key":"cit0057","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-150869"},{"key":"cit0058","doi-asserted-by":"publisher","DOI":"10.1159\/000431087"},{"key":"cit0059","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-161023"},{"key":"cit0060","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.15612"},{"key":"cit0061","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.147.1.22"},{"key":"cit0062","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2018.07.008"},{"key":"cit0063","doi-asserted-by":"publisher","DOI":"10.1097\/01.JGP.0000235689.42910.0d"},{"key":"cit0064","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2016.05.008"},{"key":"cit0065","doi-asserted-by":"publisher","DOI":"10.1097\/01.JGP.0000221334.65330.55"},{"key":"cit0066","first-page":"CD012197","volume":"5","author":"Ruthirakuhan MT","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"cit0067","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-200640"},{"key":"cit0068","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2015.05.017"},{"key":"cit0069","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-190278"},{"key":"cit0070","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12007"},{"key":"cit0071","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-021-01206-z"},{"key":"cit0072","unstructured":"US Food and Drug Administration. Guidance for industry. Codevelopment of two or more unmarketed investigational drugs for use in combination. https:\/\/www.fda.gov\/media\/80100\/download. Accessed to 2013 Jun 7."},{"key":"cit0073","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2016.07.005"},{"key":"cit0074","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-020-0884-2"},{"key":"cit0075","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01369-8"},{"key":"cit0076","first-page":"e214161","volume":"79","author":"Salloway S","year":"2021","journal-title":"JAMA Neurol"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14656566.2022.2042514","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T07:39:50Z","timestamp":1700293190000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14656566.2022.2042514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,1]]},"references-count":76,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,4,13]]}},"alternative-id":["10.1080\/14656566.2022.2042514"],"URL":"https:\/\/doi.org\/10.1080\/14656566.2022.2042514","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,1]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-08-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}